CompletedPhase 3NCT06422000

Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis

Studying Necrotizing enterocolitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tanta University
Principal Investigator
Sahar Hegazy, MD
professor and head of clinical pharmacy department, faculty of Pharmact, Tanta University, Egypt
Intervention
Pentoxifylline(drug)
Enrollment
75 target
Eligibility
All sexes
Timeline
20222023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06422000 on ClinicalTrials.gov

Other trials for Necrotizing enterocolitis

Additional recruiting or active studies for the same condition.

See all trials for Necrotizing enterocolitis

← Back to all trials